← All cases

German biotech client

AI mRNA Facility

3× early-development candidates

Background

A research organisation expanded rapidly through multiple acquisitions, driven by funding and portfolio diversification. The brief: maximise the value of those acquisitions and integrate the teams without losing momentum on candidate selection.

Solution

Personalized Solutions to structure the integration. The flagship project: an mRNA facility for in-vivo screening to accelerate candidate selection. A self-learning platform connecting synthetic biology, IVT, and immunomodulation, surfacing correlations between sequence design and cellular expression.

Results

300% increase in early-development candidates vs. the year before. 40% of scientists’ time freed for creative work rather than repetitive tasks.

inite's role

inite owned full implementation: project lead, engineering, and implementation monitoring. Architected the high-throughput solution. Negotiated with stakeholders to find the best path to the goal.

“inite's strength was to create and implement systems and structures that helped us be more efficient and effective in the way we work. The ability not to force these structures but align with the stakeholders made them a trusted advisor for us.”

COO · Global Biotech Company